(Q38467361)

3 September 2017

Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. (English)

1 reference

3 September 2017

1 reference

Bold RJ

1

1 reference

3 September 2017

Hess KR

2

1 reference

3 September 2017

Pearson AS

3

1 reference

3 September 2017

Grau AM

4

1 reference

3 September 2017

Sinicrope FA

5

1 reference

3 September 2017

Jennings M

6

1 reference

3 September 2017

McConkey DJ

7

1 reference

3 September 2017

Bucana CD

8

1 reference

3 September 2017

Cleary KR

9

1 reference

3 September 2017

Hallin PA

10

1 reference

3 September 2017

Chiao PJ

11

1 reference

3 September 2017

Abbruzzese JL

12

1 reference

3 September 2017

Evans DB

13

1 reference

3 September 2017

1 May 1999

1 reference

Journal of Gastrointestinal Surgery

3 September 2017

1 reference

3 September 2017

3

1 reference

3 September 2017

3

1 reference

3 September 2017

263-277

1 reference

https://scigraph.springernature.com/pub.10.1016/s1091-255x(99)80068-7

3 September 2017

0 references

cites work

Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer

1 reference

12 December 2020

Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis

1 reference

12 December 2020

The need for standardized pathologic staging of pancreaticoduodenectomy specimens

1 reference

12 December 2020

A model for p53-induced apoptosis

1 reference

12 December 2020

p53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base

1 reference

12 December 2020

Identification of a p53-dependent negative response element in the bcl-2 gene

1 reference

12 December 2020

Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors

1 reference

12 December 2020

The proto-oncogene Bcl-2 and its role in regulating apoptosis

1 reference

12 December 2020

Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer

1 reference

12 December 2020

Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma

1 reference

12 December 2020

bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells.

1 reference

12 December 2020

Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.

1 reference

12 December 2020

p53 in life and death

1 reference

12 December 2020

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

1 reference

12 December 2020

Immunohistochemical detection of P53 protein is not associated with a poor prognosis in non-small-cell lung cancer

1 reference

12 December 2020

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo

1 reference

12 December 2020

bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.

1 reference

12 December 2020

BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy

1 reference

12 December 2020

1 reference

12 December 2020

bcl-2 protein in non-small-cell lung carcinoma

1 reference

12 December 2020

Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.

1 reference

12 December 2020

Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein.

1 reference

12 December 2020

bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis

1 reference

12 December 2020

Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer

1 reference

12 December 2020

Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance.

1 reference

12 December 2020

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

12 December 2020

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

1 reference

12 December 2020

Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Intraoperative radiation therapy following pancreaticoduodenectomy

1 reference

12 December 2020

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor

1 reference

12 December 2020

Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer

1 reference

12 December 2020

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

1 reference

12 December 2020

K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.

1 reference

12 December 2020

Bcl-2 inhibits p53 nuclear import following DNA damage

1 reference

12 December 2020

Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma

1 reference

12 December 2020

Bcl-2 protein expression and long-term survival in breast cancer

1 reference

12 December 2020

K-ras modulates the cell cycle via both positive and negative regulatory pathways

1 reference

12 December 2020

10.1016/S1091-255X(99)80068-7

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference